Zhongnan Medical Journal Press

Home Results

A total of 76 result was found. Results that relate to Safety

Clinical analysis and risk management of drug-induced hyperuricemia

Published on Chinese Journal of Pharmacoepidemiology 2023,32(9):969-974.
6341 times 1493 times

Xiao-Lei REN Yi-Qiu ZHAN Chun-Yan ZHANG Lin HUANG Yu-Fei FENG

Hyperuricemia Drug-induced Drug safety Risk management
Details
Alirocumab in the treatment of hypercholesterolemia: a rapid health technology assessment

Published on Chinese Journal of Pharmacoepidemiology 2023,32(12):1388-1400.
8180 times 1655 times

Jian-Cheng ZHOU Chun-Mei JI Wen-Tong FANG Ying ZOU Yong-Qing WANG Yuan-Yuan FU

Alirocumab Hypercholesterolemia Safety Efficacy Cost-effectiveness Rapid health technology assessment
Details
Practice and reflection of pharmacovigilance system construction

Published on Chinese Journal of Pharmacoepidemiology 2023,32(11):1217-1224.
8954 times 2176 times

Na WANG Kang-Huai ZHANG

Pharmacovigilance Drug use safety Risk prevention and control Adverse drug reaction Medication error
Details
A retrospective study on the safety of off-indication use of pyrotinib in patients with non-small cell lung cancer

Published on Chinese Journal of Pharmacoepidemiology 2023,32(11):1238-1242.
6506 times 1701 times

Hao-Chun TANG Jun MENG Zheng-Zheng XIA Ling-Zhi REN

Non-small cell lung cancer Pyrotinib Adverse drug reaction Safety Off-indication
Details
A retrospective study of potential drug-drug interactions of dabigatran etexilate in a tertiary hospital

Published on Chinese Journal of Pharmacoepidemiology 2023,32(11):1243-1249.
6932 times 1847 times

An-Hua WEI Wen-Jing LI Yan HUANG

Dabigatran etexilate Potential drug-drug interactions Safety Retrospective study
Details
National competent authority regulation and practice of drug benefit-risk communication in the United States, European Union and China

Published on Chinese Journal of Pharmacoepidemiology 2024,33(1):19-27.
8602 times 2147 times

ZHANG Yinan WU Tingxi ZHAO Zhigang

Drug benefit-risk communication Safety communication Drug safety information Pharmacovigilance
Details
Efficacy and safety of Shenqi Fuzheng injection combined with docetaxel treatment regime in patients with metastatic castration-resistant prostate cancer

Published on Frontiers in Pharmaceutical Sciences 2023,36(11):272-278.
6125 times 1338 times

Xu-Hui CUI Ming WANG Lu ZHANG

Metastatic castration-resistant prostate cancer Shenqi Fuzheng injection Docetaxel Efficay Safety
Details
Study on the efficacy and safety of butylphthalide in combination with eureklin in the treatment of patients with acute cardioembolic stroke

Published on Frontiers in Pharmaceutical Sciences 2023,36(12):420-427.
6342 times 1176 times

Nian-Feng GUO Fei FEI Jia-Dan LI

Urinary kallidinogenase Butylphthalide Acute cardioembolic stroke Efficacy Safety
Details
Efficacy and safety of Xuefu Zhuyu decoction in patients with advanced cervical cancer

Published on Frontiers in Pharmaceutical Sciences 2023,36(12):428-434.
7325 times 1531 times

Min SHU Zhi-Hong HAN Yan HAN Xing-Mei HAN Yun-Xia ZHAI Li LI Xiao-Fei TIAN

Xuefu Zhuyu decoction Advanced cervical cancer Efficacy Safety
Details
Efficacy and safety of modified Yupingfeng granules combined with probiotics in chronic spontaneous urticaria

Published on Frontiers in Pharmaceutical Sciences 2023,36(12):442-448.
6763 times 1672 times

Ning-WANG Chun-Yan WU Zhi-Fang YAN

Chronic spontaneous urticaria Probiotics Modified Yupingfeng granules Therapeutic effect Safety
Details
Evaluation of the analgesic efficacy and safety of ketorolac in patients undergoing percutaneous vertebroplasty

Published on Frontiers in Pharmaceutical Sciences 2023,36(12):449-455.
6356 times 1171 times

Wu-Jun YUAN Ping-An XU Zhen LIANG Lei WANG

Ketorolac Percutaneous vertebroplasty Pain relief Safety
Details
Date mining and analysis of adverse events of levofloxacin in children: a real world study based on FAERS database

Published on Frontiers in Pharmaceutical Sciences 2024,27(1):85-92.
7281 times 1595 times

GUAN Xiaochan LIU Zhijun FANG Zhenwei XIANG Zhuo LIU Nannan

Child safety Mycoplasma pneumoniae Adverse events FAERS database
Details
Evaluation of efficacy and safety of Sintilimab+Bevacizumab combined with PP regime in patients with advanced non-squamous non-small cell lung cancer

Published on Frontiers in Pharmaceutical Sciences 2024,27(1):93-99.
5245 times 1365 times

SHEN Junjie JIN Jianwei RUAN Zekun ZHANG Weiping

Advanced non-squamous non-small lung cell cancer Sintilimab Bevacizumab Efficay Safety
Details
Comparison of effectiveness, safety, and economy of generic and original levetiracetam concentrated solution for injection: a real-world study

Published on Chinese Journal of Pharmacoepidemiology 2024,33(2):152-157.
7379 times 1514 times

FENG Yingnan DONG Xianzhe PENG Jing WANG Ke WANG Zhizhou LUAN Jiajie ZHANG Lan YUE Xiaolin

Levetiracetam concentrated solution for injection Generic drugs Original drugs Effectiveness Safety Economy Drug centralized procurement Real-world study
Details
Clinical efficacy and safety evaluation observation of vitamin D combined with atomoxetine hydrochloride in the treatment of attention deficit hyperactivity disorder in children

Published on Frontiers in Pharmaceutical Sciences 2024,27(2):287-294.
10161 times 2175 times

QIN Yunfeng LING Yinjie LANG Yan

Vitamin D Atomoxetine hydrochloride Attention deficit hyperactivity disorder Clinical efficacy Safety
Details